Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9BPC

Cryo-EM structure of P2X3 receptor in complex with camlipixant

This is a non-PDB format compatible entry.
Summary for 9BPC
Entry DOI10.2210/pdb9bpc/pdb
Related5svj 5svk
EMDB information44771
DescriptorP2X purinoceptor, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Camlipixant, ... (4 entities in total)
Functional Keywordsp2x3, camlipixant, cryo-em, ion channel, receptor, membrane protein
Biological sourceCanis lupus (gray wolf)
Total number of polymer chains3
Total formula weight124744.76
Authors
Thach, T.,Subramanian, R. (deposition date: 2024-05-07, release date: 2025-03-19)
Primary citationThach, T.,Dhanabalan, K.,Nandekar, P.P.,Stauffer, S.,Heisler, I.,Alvarado, S.,Snyder, J.,Subramanian, R.
Mechanistic insights into the selective targeting of P2X3 receptor by camlipixant antagonist.
J.Biol.Chem., 301:108109-108109, 2025
Cited by
PubMed Abstract: ATP-activated P2X3 receptors play a pivotal role in chronic cough, affecting more than 10% of the population. Despite the challenges posed by the highly conserved structure of P2X receptors, efforts to develop selective drugs targeting P2X3 have led to the development of camlipixant, a potent, selective P2X3 antagonist. However, the mechanisms of receptor desensitization, ion permeation, and structural basis of camlipixant binding to P2X3 remain unclear. Here, we report a cryo-EM structure of camlipixant-bound P2X3, revealing a previously undiscovered selective drug-binding site in the receptor. Our findings also demonstrate that conformational changes in the upper body domain, including the turret and camlipixant-binding pocket, play a critical role: turret opening facilitates P2X3 channel closure to a radius of 0.7 Å, hindering cation transfer, whereas turret closure leads to channel opening. Structural and functional studies combined with molecular dynamics simulations provide a comprehensive understanding of camlipixant's selective inhibition of P2X3, offering a foundation for future drug development targeting this receptor.
PubMed: 39706278
DOI: 10.1016/j.jbc.2024.108109
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.44 Å)
Structure validation

237735

数据于2025-06-18公开中

PDB statisticsPDBj update infoContact PDBjnumon